NCT02886598View on ClinicalTrials.gov

Safety and Efficacy of Firmagon® (Degarelix) for Injection

CompletedOBSERVATIONAL
Enrollment

368

Participants

Timeline

Start Date

September 30, 2016

Primary Completion Date

March 26, 2019

Study Completion Date

March 26, 2019

Conditions
Prostate Cancer
Interventions
DRUG

degarelix

Trial Locations (1)

Unknown

Gangnam Severance Hospital (there may be other sites in this country), Seoul

Sponsors
All Listed Sponsors
lead

Ferring Pharmaceuticals

INDUSTRY

NCT02886598 - Safety and Efficacy of Firmagon® (Degarelix) for Injection | Biotech Hunter | Biotech Hunter